Brought to you by 
Horizon Discovery Group PLC acquires Haplogen Genomics GMBH
10 Sep 2020
Executive Summary
Horizon Discovery Group PLC (life science tools and services) acquired Haplogen Genomics GMBH (genomics platform through use of haploid cells) for approximately $14.9mm. The acquisition will have a $9mm up-front payment funded from cash and the issuance of new shares, plus $5.9mm in 2015/2016 earn-outs.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Horizon Discovery Group PLC acquires Haplogen Genomics GMBH
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice